Dr. Wayne Danter is the founder of 123Genetix, and a pioneer in the evolving interface between artificial intelligence (“AI”) and pharmacotherapeutics. Prior to founding 123Genetix, Dr. Danter was the Chief Executive Officer and co-founder of Critical Outcome Technologies Inc., where he invented a proprietary, AI-based technology platform, which utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed from disease specific drug discovery and chemical optimization through preclinical testing.
Dr. Danter trained at the University of Western Ontario in Internal Medicine and Clinical Pharmacology. Prior to founding Critical Outcome Technologies, he was an Associate Professor of Medicine at the University of Western Ontario. His clinical focus at the University was in General Cardiology, Cardiovascular Diseases associated with HIV, and Cardiovascular Risk Management. Dr. Danter’s initial research focused on the medical application of AI technologies to disease diagnosis and outcome prediction. His research has been published in peer-reviewed publications and he has presented at numerous international meetings.